QIPT
Quipt Home Medical Corp
$
2.620
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
2.670
Open
2.590
VWAP
2.60
Vol
1.00M
Mkt Cap
113.82M
Low
2.530
Amount
2.61M
EV/EBITDA(TTM)
5.34
Total Shares
42.57M
EV
194.85M
EV/OCF(TTM)
6.20
P/S(TTM)
0.47
Quipt Home Medical Corp. is a home medical equipment provider. The Company provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. The Company’s comprehensive solutions support patients dealing with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. The Company serves patients approximately 26 states in the United States. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, home medical equipment, and custom mobility solutions.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
70.05M
+14.35%
-0.060
-14.29%
59.04M
-3.88%
-0.055
+83.33%
58.42M
+1.7%
-0.055
-21.43%
Estimates Revision
The market is revising Upward the revenue expectations for Quipt Home Medical Corp. (QIPT) for FY2025, with the revenue forecasts being adjusted by 0.13% over the past three months. During the same period, the stock price has changed by 48.02%.
Revenue Estimates for FY2025
Revise Upward
+0.13%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-22.26%
In Past 3 Month
Stock Price
Go Up
+48.02%
In Past 3 Month
3 Analyst Rating
23.28% Upside
Wall Street analysts forecast QIPT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for QIPT is 3.23 USD with a low forecast of 2.30 USD and a high forecast of 4.85 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
2 Hold
0 Sell
Moderate Buy
23.28% Upside
Current: 2.620
Low
2.30
Averages
3.23
High
4.85
23.28% Upside
Current: 2.620
Low
2.30
Averages
3.23
High
4.85
Canaccord
Richard Close
Hold
maintain
2025-08-19
Reason
Canaccord
Richard Close
Price Target
2025-08-19
maintain
Hold
Reason
Canaccord analyst Richard Close raised the firm's price target on Quipt Home Medical (QIPT) to $2.30 from $1.70 and keeps a Hold rating on the shares. The firm said they demonstrated improvement in 3Q with a sequential uptick across metrics, though it remains down year over year as the company works through some headwinds such as its Humana MA (HUM) capitated contract and disposable supply contract non-renewal.
Canaccord
Richard Close
Buy
to
Hold
downgrade
$4
2025-05-14
Reason
Canaccord
Richard Close
Price Target
$4
2025-05-14
downgrade
Buy
to
Hold
Reason
Canaccord analyst Richard Close downgraded yesterday afternoon Quipt Home Medical to Hold from Buy with a price target of $1.70, down from $4. Quipt is "currently enduring several revenue headwinds that have stunted organic growth" over the last year, the analyst tells investors in a research note. The firm says that following fiscal Q2 results that delivered a 6% revenue decline, the headwinds look to be continuing longer than originally expected. The loss of Humana HMO clients with the initial transition to capitated agreements with competitors looks to have "increasingly bled" over to PPO members as the capitated contract was again cited in the revenue performance, contends Canaccord.
Bill Sutherland
Buy
downgrade
$6 -> $4
2025-05-14
Reason
Bill Sutherland
Price Target
$6 -> $4
2025-05-14
downgrade
Buy
Reason
Benchmark analyst Bill Sutherland lowered the firm's price target on Quipt Home Medical to $4 from $6 and keeps a Buy rating on the shares after revenue missed expectations in fiscal Q2. On a positive note, Quipt continues to see no negative impact from GLP-1 medications on demand for sleep therapy set ups and supplies, like other respiratory-focused home medical equipment companies, the analyst noted.
Canaccord
Buy
to
Hold
downgrade
$4
2025-05-13
Reason
Canaccord
Price Target
$4
2025-05-13
downgrade
Buy
to
Hold
Reason
Canaccord downgraded Quipt Home Medical to Hold from Buy with a price target of $1.70, down from $4.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Quipt Home Medical Corp (QIPT.O) is -15.20, compared to its 5-year average forward P/E of 3.16. For a more detailed relative valuation and DCF analysis to assess Quipt Home Medical Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
3.16
Current PE
-15.20
Overvalued PE
129.56
Undervalued PE
-123.24
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Undervalued
5Y Average EV/EBITDA
4.79
Current EV/EBITDA
2.92
Overvalued EV/EBITDA
6.24
Undervalued EV/EBITDA
3.34
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
0.92
Current PS
0.35
Overvalued PS
1.35
Undervalued PS
0.49
Financials
Annual
Quarterly
FY2025Q3
YoY :
-4.07%
58.29M
Total Revenue
FY2025Q3
YoY :
-1183.97%
-2.57M
Operating Profit
FY2025Q3
YoY :
+89.54%
-3.03M
Net Income after Tax
FY2025Q3
YoY :
+75.00%
-0.07
EPS - Diluted
FY2025Q3
YoY :
-40.14%
2.85M
Free Cash Flow
FY2025Q3
YoY :
+1.71%
55.20
Gross Profit Margin - %
FY2025Q3
YoY :
+97.34%
-5.19
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
41.6K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
246.5K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
41.6K
USD
Months
0-12
0
0.0
USD
Months
QIPT News & Events
Events Timeline
2025-08-25 (ET)
2025-08-25
08:35:05
Forager Capital proposes to buy Quipt for $3.10 per share in cash.
2025-08-12 (ET)
2025-08-12
07:35:07
Quipt Home partners with three major health systems to form joint venture
2025-07-07 (ET)
2025-07-07
07:37:38
Quipt Home Medical acquires full-service durable medical equipment provider
Sign Up For More Events
Sign Up For More Events
News
8.5
08-25NewsfilterPinnedForager Capital Management Presents Fully Funded Offer to Purchase Quipt Home Medical at $3.10 Per Share in Cash
7.0
08-25Yahoo FinanceResumption of Trading by Canadian Investment Regulatory Organization - QIPT
8.5
08-25SeekingAlphaForager Capital suggests acquisition of Quipt Home Medical; stock rises 22%
Sign Up For More News
People Also Watch
VGAS
Verde Clean Fuels Inc
3.010
USD
+6.74%
EUDA
EUDA Health Holdings Ltd
2.250
USD
-15.73%
LCTX
Lineage Cell Therapeutics Inc
1.250
USD
+6.84%
HURC
Hurco Companies Inc
17.750
USD
+0.51%
MNSB
MainStreet Bancshares Inc
22.930
USD
+1.01%
ULBI
Ultralife Corp
6.950
USD
+0.29%
DTI
Drilling Tools International Corp
1.860
USD
-2.62%
OPOF
Old Point Financial Corp
41.900
USD
+0.60%
FAQ
What is Quipt Home Medical Corp (QIPT) stock price today?
The current price of QIPT is 2.62 USD — it has increased 0.38 % in the last trading day.
What is Quipt Home Medical Corp (QIPT)'s business?
What is the price predicton of QIPT Stock?
What is Quipt Home Medical Corp (QIPT)'s revenue for the last quarter?
What is Quipt Home Medical Corp (QIPT)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Quipt Home Medical Corp (QIPT)'s fundamentals?
How many employees does Quipt Home Medical Corp (QIPT). have?